Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00001620 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Screening for Hematology Branch Protocols

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 425 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Re-verified, no change to tracked fields
  4. Re-verified, no change to tracked fields
  5. Eligibility criteria expanded, about 1 word
Show 45 earlier versionsHide 45 earlier versions
  1. 16 versions Re-verified since Jul 7, 2026, no change to tracked fieldsv405-v420
  2. Study Status, Eligibility, Contacts/Locationsv404
  3. 28 versions Re-verified since Sep 30, 2025, no change to tracked fieldsv376-v403
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study allows the evaluation of subjects in order to determine their ability to safely participate in other active research studies. After subjects complete the screening process, they will be offered the opportunity to participate in an active research study, or if no appropriate studies are available information and recommendations will be provided for other treatment options....
Trial Details
NCT Number NCT00001620
Lead Sponsor National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hematologic Disease and Disorders, Donors, Healthy Volunteer
Enrollment 10,000 participants
Start Date
Updated on ClinicalTrials.gov